Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Mar 18;9(3):e92388.
doi: 10.1371/journal.pone.0092388. eCollection 2014.

Statins for the prevention of stroke: a meta-analysis of randomized controlled trials

Affiliations
Meta-Analysis

Statins for the prevention of stroke: a meta-analysis of randomized controlled trials

Wen Wang et al. PLoS One. .

Abstract

Background: Stroke is a frequently encountered clinical event that has a detrimental impact on the quality of life. Evidence has increasingly shown that statins can substantially reduce the risk of coronary heart disease. However, it remains to be determined whether statins are definitively effective in preventing stroke.

Methods: We systematically searched the PubMed, Embase, and Central databases for studies that compared the effects of statins and placebo in patients at high risk for stroke. The outcome measures were overall incidence of stroke, incidence of fatal stroke, and incidence of hemorrhagic stroke.

Results: Eighteen randomized controlled trials satisfied all the inclusion criteria for the meta-analysis. The analysis revealed that statins reduced the overall incidence of stroke than placebo (odds ratio [OR]: 0.80; 95% confidence interval [CI]: 0.74-0.87; P<0.00001). In particular, statins showed efficacy in reducing the incidence of fatal stroke (OR: 0.90; 95% CI: 0.67-1.21; P = 0.47) and hemorrhagic stroke (OR: 0.87; 95% CI: 0.60-1.25; P = 0.45). On the contrary, they were found to increase the overall incidence of stroke (OR: 1.12; 95% CI: 0.89-1.41; P = 0.32) and fatal stroke (OR: 1.37; 95% CI: 0.93-2.03; P = 0.11) in renal transplant recipients and patients undergoing regular hemodialysis.

Conclusion: The results of this analysis suggest that statins may be beneficial in reducing the overall incidence of stroke and they may decrease the risk of fatal stroke and hemorrhagic stroke. However, statins should be used with caution in patients with a history of renal transplantation, regular hemodialysis, transient ischemic attack, or stroke. Further analyses should focus on multicentre, double-blind, placebo-controlled randomized trials with data stratification according to the nature of primary diseases and dose-effect relationship, to clarify the benefits of statins in protection against stroke.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow chart indicating the selection process for this meta-analysis.
Figure 2
Figure 2. Risk of bias graph.
Figure 3
Figure 3. Risk of bias summary.
Figure 4
Figure 4. Forest plot for overall stroke incidence.
Figure 5
Figure 5. Forest plot for fatal stroke incidence.
Figure 6
Figure 6. Forest plot for hemorrhagic stroke incidence.
Figure 7
Figure 7. Funnel plot for 18 randomized controlled trials.

References

    1. Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, et al. (1997) American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. Stroke 28: 1501–1506. - PubMed
    1. Kent DM (2006) Stroke—an equal opportunity for the initiation of statin therapy. N Engl J Med 355: 613–615. - PubMed
    1. Robinson JG, Smith B, Maheshwari N, Schrott H (2005) Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 46: 1855–1862. - PubMed
    1. Calabro P, Yeh ET (2005) The pleiotropic effects of statins. Curr Opin Cardiol 20: 541–546. - PubMed
    1. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, et al. (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53: 743–751. - PubMed

Publication types

Substances